PDB Short entry for 3KCG HEADER HYDROLASE, HYDROLASE INHIBITOR 21-OCT-09 3KCG TITLE CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR IXA LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: EGF2; COMPND 5 SYNONYM: FACTOR IX, CHRISTMAS FACTOR, PLASMA THROMBOPLASTIN COMPND 6 COMPONENT, PTC; COMPND 7 EC: 3.4.21.22; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: COAGULATION FACTOR IXA HEAVY CHAIN; COMPND 11 CHAIN: H; COMPND 12 SYNONYM: FACTOR IX, CHRISTMAS FACTOR, PLASMA THROMBOPLASTIN COMPND 13 COMPONENT, PTC; COMPND 14 EC: 3.4.21.22; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: ANTITHROMBIN-III; COMPND 19 CHAIN: I; COMPND 20 SYNONYM: ATIII; COMPND 21 ENGINEERED: YES; COMPND 22 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: F9; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: SERPINC1, AT3, PRO0309; SOURCE 20 EXPRESSION_SYSTEM_CELL: BHK KEYWDS MICHAELIS COMPLEX, BLOOD COAGULATION, CALCIUM, DISULFIDE BOND, EGF- KEYWDS 2 LIKE DOMAIN, GLYCOPROTEIN, HEMOPHILIA, HYDROLASE, PHARMACEUTICAL, KEYWDS 3 PROTEASE, SECRETED, SERINE PROTEASE, SULFATION, ZYMOGEN, HEPARIN- KEYWDS 4 BINDING, PROTEASE INHIBITOR, SERINE PROTEASE INHIBITOR, KEYWDS 5 THROMBOPHILIA, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HUNTINGTON,D.J.D.JOHNSON REVDAT 4 01-NOV-23 3KCG 1 REMARK REVDAT 3 10-NOV-21 3KCG 1 SEQADV HETSYN REVDAT 2 29-JUL-20 3KCG 1 COMPND REMARK SEQADV HET REVDAT 2 2 1 HETNAM FORMUL LINK SITE REVDAT 2 3 1 ATOM REVDAT 1 02-FEB-10 3KCG 0 JRNL AUTH D.J.JOHNSON,J.LANGDOWN,J.A.HUNTINGTON JRNL TITL MOLECULAR BASIS OF FACTOR IXA RECOGNITION BY JRNL TITL 2 HEPARIN-ACTIVATED ANTITHROMBIN REVEALED BY A 1.7-A STRUCTURE JRNL TITL 3 OF THE TERNARY COMPLEX. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 645 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20080729 JRNL DOI 10.1073/PNAS.0910144107 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.05 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2168682.340 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 112546 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5670 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 17733 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 951 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5492 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 204 REMARK 3 SOLVENT ATOMS : 667 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.52000 REMARK 3 B22 (A**2) : -0.83000 REMARK 3 B33 (A**2) : 0.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.290 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.940 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 52.45 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3KCG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1000055817. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 112588 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 58.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : 0.06900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : 0.58000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1E03, 1RFN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25M AMMONIUM SULFATE, 19.5% PEG REMARK 280 3350, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.39000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.61500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.22000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.61500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.39000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.22000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, I, A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER L 138 REMARK 465 GLN L 139 REMARK 465 THR L 140 REMARK 465 SER L 141 REMARK 465 LYS L 142 REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 LYS I 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET L 84 CG SD CE REMARK 470 THR L 87 OG1 CG2 REMARK 470 LYS L 100 CD CE NZ REMARK 470 SER L 102 OG REMARK 470 ASP L 104 CG OD1 OD2 REMARK 470 LYS L 106 CE NZ REMARK 470 GLU L 113 OE1 OE2 REMARK 470 ARG L 116 CG CD NE CZ NH1 NH2 REMARK 470 GLU L 119 CG CD OE1 OE2 REMARK 470 GLU L 125 CG CD OE1 OE2 REMARK 470 LYS H 23 CE NZ REMARK 470 LYS H 82 CD CE NZ REMARK 470 LYS H 173 CD CE NZ REMARK 470 SER I 3 OG REMARK 470 LYS I 11 CE NZ REMARK 470 ILE I 15 CG1 CG2 CD1 REMARK 470 GLU I 27 CG CD OE1 OE2 REMARK 470 GLN I 38 CG CD OE1 NE2 REMARK 470 LYS I 39 CG CD CE NZ REMARK 470 GLU I 42 CD OE1 OE2 REMARK 470 ARG I 132 CD NE CZ NH1 NH2 REMARK 470 LYS I 136 CD CE NZ REMARK 470 LYS I 188 CD CE NZ REMARK 470 LYS I 222 CE NZ REMARK 470 LYS I 257 CG CD CE NZ REMARK 470 GLU I 289 CG CD OE1 OE2 REMARK 470 LYS I 294 CG CD CE NZ REMARK 470 LYS I 297 CD CE NZ REMARK 470 THR I 300 OG1 CG2 REMARK 470 GLU I 302 CG CD OE1 OE2 REMARK 470 VAL I 303 CG1 CG2 REMARK 470 GLU I 306 CD OE1 OE2 REMARK 470 GLU I 312 CD OE1 OE2 REMARK 470 GLU I 313 CD OE1 OE2 REMARK 470 VAL I 431 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS H 182 CA - CB - SG ANGL. DEV. = 8.8 DEGREES REMARK 500 CYS H 220 CA - CB - SG ANGL. DEV. = 7.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP L 85 -62.55 170.75 REMARK 500 GLN L 97 -87.26 -116.07 REMARK 500 ASP L 104 62.17 68.06 REMARK 500 GLN L 121 14.17 59.40 REMARK 500 HIS H 71 -63.57 -134.31 REMARK 500 ASN H 97 118.23 124.60 REMARK 500 ASN H 97 121.63 123.54 REMARK 500 ASN H 115 -168.47 -160.60 REMARK 500 SER H 214 -73.49 -124.97 REMARK 500 GLU H 219 -154.05 64.26 REMARK 500 MET I 17 44.81 -143.75 REMARK 500 ASN I 96 -139.87 51.67 REMARK 500 ASN I 96 -139.87 51.37 REMARK 500 SER I 138 -179.56 -175.43 REMARK 500 ASN I 178 50.09 -141.59 REMARK 500 GLU I 205 -0.05 70.85 REMARK 500 ASP I 277 -18.72 66.26 REMARK 500 ASP I 277 -16.16 66.26 REMARK 500 GLU I 289 -23.89 91.56 REMARK 500 LEU I 299 110.02 -168.92 REMARK 500 ASN I 396 85.08 82.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H 500 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU H 70 OE2 REMARK 620 2 ASN H 72 O 86.5 REMARK 620 3 GLU H 75 O 164.5 83.6 REMARK 620 4 GLU H 77 OE1 81.2 89.1 110.5 REMARK 620 5 GLU H 80 OE2 101.2 170.5 90.0 86.6 REMARK 620 6 HOH H 267 O 84.1 95.8 85.0 164.2 90.6 REMARK 620 N 1 2 3 4 5 DBREF 3KCG L 85 142 UNP P00740 FA9_HUMAN 131 188 DBREF 3KCG H 16 245 UNP P00740 FA9_HUMAN 227 461 DBREF 3KCG I 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQADV 3KCG MET L 84 UNP P00740 INITIATING METHIONINE SEQADV 3KCG ALA H 195 UNP P00740 SER 411 ENGINEERED MUTATION SEQADV 3KCG ALA I 137 UNP P01008 SER 169 ENGINEERED MUTATION SEQRES 1 L 59 MET ASP VAL THR CYS ASN ILE LYS ASN GLY ARG CYS GLU SEQRES 2 L 59 GLN PHE CYS LYS ASN SER ALA ASP ASN LYS VAL VAL CYS SEQRES 3 L 59 SER CYS THR GLU GLY TYR ARG LEU ALA GLU ASN GLN LYS SEQRES 4 L 59 SER CYS GLU PRO ALA VAL PRO PHE PRO CYS GLY ARG VAL SEQRES 5 L 59 SER VAL SER GLN THR SER LYS SEQRES 1 H 235 VAL VAL GLY GLY GLU ASP ALA LYS PRO GLY GLN PHE PRO SEQRES 2 H 235 TRP GLN VAL VAL LEU ASN GLY LYS VAL ASP ALA PHE CYS SEQRES 3 H 235 GLY GLY SER ILE VAL ASN GLU LYS TRP ILE VAL THR ALA SEQRES 4 H 235 ALA HIS CYS VAL GLU THR GLY VAL LYS ILE THR VAL VAL SEQRES 5 H 235 ALA GLY GLU HIS ASN ILE GLU GLU THR GLU HIS THR GLU SEQRES 6 H 235 GLN LYS ARG ASN VAL ILE ARG ILE ILE PRO HIS HIS ASN SEQRES 7 H 235 TYR ASN ALA ALA ILE ASN LYS TYR ASN HIS ASP ILE ALA SEQRES 8 H 235 LEU LEU GLU LEU ASP GLU PRO LEU VAL LEU ASN SER TYR SEQRES 9 H 235 VAL THR PRO ILE CYS ILE ALA ASP LYS GLU TYR THR ASN SEQRES 10 H 235 ILE PHE LEU LYS PHE GLY SER GLY TYR VAL SER GLY TRP SEQRES 11 H 235 GLY ARG VAL PHE HIS LYS GLY ARG SER ALA LEU VAL LEU SEQRES 12 H 235 GLN TYR LEU ARG VAL PRO LEU VAL ASP ARG ALA THR CYS SEQRES 13 H 235 LEU ARG SER THR LYS PHE THR ILE TYR ASN ASN MET PHE SEQRES 14 H 235 CYS ALA GLY PHE HIS GLU GLY GLY ARG ASP SER CYS GLN SEQRES 15 H 235 GLY ASP ALA GLY GLY PRO HIS VAL THR GLU VAL GLU GLY SEQRES 16 H 235 THR SER PHE LEU THR GLY ILE ILE SER TRP GLY GLU GLU SEQRES 17 H 235 CYS ALA MET LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 H 235 SER ARG TYR VAL ASN TRP ILE LYS GLU LYS THR LYS LEU SEQRES 19 H 235 THR SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS ALA SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS MODRES 3KCG ASN I 96 ASN GLYCOSYLATION SITE MODRES 3KCG ASN I 155 ASN GLYCOSYLATION SITE MODRES 3KCG ASN I 192 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET FUC A 2 10 HET NAG B 1 14 HET NAG B 2 14 HET MAN B 3 11 HET NAG C 1 14 HET FUC C 2 10 HET Z9L D 1 25 HET Z9K D 2 17 HET GU6 D 3 23 HET GU1 D 4 14 HET Z9H D 5 21 HET CA H 500 1 HET MPD I5276 8 HET MPD I5277 8 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM Z9L METHYL 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSIDE HETNAM Z9K 3-O-METHYL-2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM GU6 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM GU1 2,3-DI-O-METHYL-BETA-D-GLUCOPYRANURONIC ACID HETNAM Z9H 3,4-DI-O-METHYL-2,6-DI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GU6 2,3,6-TRI-O-SULFONATO-ALPHA-D-GLUCOPYRANOSE; 2,3,6-TRI- HETSYN 2 GU6 O-SULFO-ALPHA-D-GLUCOSE; 2,3,6-TRI-O-SULFO-D-GLUCOSE; HETSYN 3 GU6 2,3,6-TRI-O-SULFO-GLUCOSE HETSYN GU1 2,3-DI-O-METHYL-BETA-D-GLUCURONIC ACID; 2,3-DI-O- HETSYN 2 GU1 METHYL-D-GLUCURONIC ACID; 2,3-DI-O-METHYL-GLUCURONIC HETSYN 3 GU1 ACID FORMUL 4 NAG 4(C8 H15 N O6) FORMUL 4 FUC 2(C6 H12 O5) FORMUL 5 MAN C6 H12 O6 FORMUL 7 Z9L C7 H14 O15 S3 FORMUL 7 Z9K C7 H12 O10 S FORMUL 7 GU6 C6 H12 O15 S3 FORMUL 7 GU1 C8 H14 O7 FORMUL 7 Z9H C8 H16 O12 S2 FORMUL 8 CA CA 2+ FORMUL 9 MPD 2(C6 H14 O2) FORMUL 11 HOH *667(H2 O) HELIX 1 1 ILE L 90 CYS L 95 5 6 HELIX 2 2 ALA H 55 VAL H 59 5 5 HELIX 3 3 ASN H 95 ASN H 97 5 5 HELIX 4 4 ASP H 125 LYS H 132 1 10 HELIX 5 5 ASP H 164 ARG H 170 1 7 HELIX 6 6 TYR H 234 LYS H 243 1 10 HELIX 7 7 ASP I 6 ALA I 10 5 5 HELIX 8 8 ASN I 45 LYS I 70 1 26 HELIX 9 9 SER I 79 LEU I 92 1 14 HELIX 10 10 CYS I 95 PHE I 106 1 12 HELIX 11 11 SER I 112 GLN I 118 1 7 HELIX 12 12 GLN I 118 ASN I 135 1 18 HELIX 13 13 ASN I 155 GLY I 167 1 13 HELIX 14 14 ASP I 174 THR I 194 1 21 HELIX 15 15 SER I 230 THR I 234 5 5 HELIX 16 16 ALA I 264 GLY I 266 5 3 HELIX 17 17 SER I 291 GLU I 298 1 8 HELIX 18 18 THR I 300 LEU I 311 1 12 HELIX 19 19 LEU I 331 MET I 338 1 8 HELIX 20 20 VAL I 341 SER I 345 5 5 SHEET 1 A 2 PHE L 98 ASN L 101 0 SHEET 2 A 2 VAL L 107 SER L 110 -1 O VAL L 108 N LYS L 100 SHEET 1 B 2 TYR L 115 LEU L 117 0 SHEET 2 B 2 CYS L 124 PRO L 126 -1 O GLU L 125 N ARG L 116 SHEET 1 C 6 GLU H 20 ASP H 21 0 SHEET 2 C 6 GLN H 156 VAL H 163 -1 O TYR H 157 N GLU H 20 SHEET 3 C 6 SER H 135 GLY H 140 -1 N GLY H 136 O VAL H 160 SHEET 4 C 6 PRO H 198 VAL H 203 -1 O VAL H 200 N TYR H 137 SHEET 5 C 6 THR H 206 GLY H 216 -1 O THR H 206 N VAL H 203 SHEET 6 C 6 ALA I 391 GLY I 392 -1 O ALA I 391 N GLY H 216 SHEET 1 D 6 GLU H 20 ASP H 21 0 SHEET 2 D 6 GLN H 156 VAL H 163 -1 O TYR H 157 N GLU H 20 SHEET 3 D 6 MET H 180 ALA H 183 -1 O CYS H 182 N VAL H 163 SHEET 4 D 6 GLY H 226 LYS H 230 -1 O TYR H 228 N PHE H 181 SHEET 5 D 6 THR H 206 GLY H 216 -1 N TRP H 215 O ILE H 227 SHEET 6 D 6 ALA I 391 GLY I 392 -1 O ALA I 391 N GLY H 216 SHEET 1 E 7 GLN H 30 ASN H 34 0 SHEET 2 E 7 CYS H 42 ASN H 48 -1 O CYS H 42 N LEU H 33 SHEET 3 E 7 TRP H 51 THR H 54 -1 O TRP H 51 N VAL H 47 SHEET 4 E 7 ALA H 104 LEU H 108 -1 O LEU H 106 N ILE H 52 SHEET 5 E 7 GLN H 81 PRO H 90 -1 N ILE H 89 O LEU H 105 SHEET 6 E 7 THR H 65 ALA H 68 -1 N VAL H 66 O ARG H 83 SHEET 7 E 7 GLN H 30 ASN H 34 -1 N ASN H 34 O THR H 65 SHEET 1 F 7 ILE I 76 LEU I 78 0 SHEET 2 F 7 THR I 419 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 F 7 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 F 7 ILE I 279 LEU I 285 -1 N VAL I 282 O PHE I 411 SHEET 5 F 7 GLN I 268 PRO I 273 -1 N LEU I 270 O LEU I 283 SHEET 6 F 7 SER I 246 ARG I 262 -1 N ARG I 261 O VAL I 269 SHEET 7 F 7 ARG I 235 TYR I 240 -1 N PHE I 239 O CYS I 247 SHEET 1 G 8 ILE I 76 LEU I 78 0 SHEET 2 G 8 THR I 419 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 G 8 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 G 8 ILE I 279 LEU I 285 -1 N VAL I 282 O PHE I 411 SHEET 5 G 8 GLN I 268 PRO I 273 -1 N LEU I 270 O LEU I 283 SHEET 6 G 8 SER I 246 ARG I 262 -1 N ARG I 261 O VAL I 269 SHEET 7 G 8 GLU I 312 PRO I 321 -1 O MET I 320 N MET I 252 SHEET 8 G 8 VAL I 400 LYS I 403 1 O PHE I 402 N HIS I 319 SHEET 1 H 5 GLN I 171 LEU I 173 0 SHEET 2 H 5 SER I 138 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 H 5 LEU I 213 GLY I 223 -1 O TYR I 220 N VAL I 141 SHEET 4 H 5 ASP I 366 VAL I 375 1 O PHE I 368 N LEU I 215 SHEET 5 H 5 PHE I 323 SER I 330 -1 N PHE I 323 O VAL I 375 SSBOND 1 CYS L 88 CYS L 99 1555 1555 2.03 SSBOND 2 CYS L 95 CYS L 109 1555 1555 2.03 SSBOND 3 CYS L 111 CYS L 124 1555 1555 2.03 SSBOND 4 CYS L 132 CYS H 122 1555 1555 2.04 SSBOND 5 CYS H 42 CYS H 58 1555 1555 2.04 SSBOND 6 CYS H 168 CYS H 182 1555 1555 2.02 SSBOND 7 CYS H 191 CYS H 220 1555 1555 2.04 SSBOND 8 CYS I 8 CYS I 128 1555 1555 2.04 SSBOND 9 CYS I 21 CYS I 95 1555 1555 2.03 SSBOND 10 CYS I 247 CYS I 430 1555 1555 2.03 LINK ND2 ASN I 96 C1 NAG A 1 1555 1555 1.45 LINK ND2 ASN I 155 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN I 192 C1 NAG C 1 1555 1555 1.45 LINK O6 NAG A 1 C1 FUC A 2 1555 1555 1.40 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.43 LINK O4 NAG B 2 C1 MAN B 3 1555 1555 1.39 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.40 LINK O4 Z9L D 1 C1 Z9K D 2 1555 1555 1.44 LINK O4 Z9K D 2 C1 GU6 D 3 1555 1555 1.44 LINK O4 GU6 D 3 C1 GU1 D 4 1555 1555 1.44 LINK O4 GU1 D 4 C1 Z9H D 5 1555 1555 1.44 LINK OE2 GLU H 70 CA CA H 500 1555 1555 2.26 LINK O ASN H 72 CA CA H 500 1555 1555 2.36 LINK O GLU H 75 CA CA H 500 1555 1555 2.20 LINK OE1 GLU H 77 CA CA H 500 1555 1555 2.45 LINK OE2 GLU H 80 CA CA H 500 1555 1555 2.33 LINK O HOH H 267 CA CA H 500 1555 1555 2.22 CRYST1 78.780 88.440 147.230 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012694 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011307 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006792 0.00000